查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861523

切片穿刺针市场按类型、手术、类别、材质、采购管道、应用和最终用户划分－全球预测（2025-2032 年）

Biopsy Needles Market by Type, Procedure, Category, Material, Purchasing Channel, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，切片穿刺针市场规模将达到 11.695 亿美元，复合年增长率为 5.96%。

关键市场统计数据
基准年 2024 7.3549亿美元
预计年份：2025年 7.7771亿美元
预测年份 2032 11.695亿美元
复合年增长率 (%) 5.96%

本文策略性地介绍了切片穿刺针创新和采购为何与不断发展的诊断路径、临床工作流程以及医疗环境的转型直接相关。

切片穿刺针是现代诊断流程中不可或缺的组成部分，它使临床医生能够以微创方式提取组织并做出明确的临床决策。过去十年，影像引导、针体设计和材料科学的不断进步，拓展了经皮切片检查术在各个器官系统的临床应用范围。随着临床路径向更早期、影像主导的检测和精准医疗方向发展，活检针本身已不再只是一个被动的工具；它成为了手术效率、安全性和后续诊断产量的交汇点。因此，製造商、临床医生和采购经理必须以全面的方式评估产品性能、手术适用性和生命週期经济性。此外，从住院病房到门诊手术中心和诊断诊所，不断变化的医疗环境正在改变设备需求和服务预期，促使製造商优化其产品系列和商业策略。在此背景下，相关人员应优先考虑清晰了解手术要求、临床医生工作流程以及设备特性与诊断结果之间的相互作用。这样做，产品开发和商业化策略可以更好地与现代切片检查实践的实际情况以及临床医生、患者和医疗保健系统不断变化的期望相一致。

诊断影像、即时护理转型以及监管和数数位化需求的融合正在推动重大变革，重新定义切片穿刺针的研发和采购。

受技术创新、临床实践变革以及对诊断准确性和患者体验日益增长的期望所驱动，切片穿刺针领域正经历着变革性的转变。针体形状、涂层和成像相容设计的进步，在减少取样误差和手术时间的同时，也拓展了临床医师可进行的微创手术范围。同时，真空抽吸系统和改进的影像导引平台的日益普及，正在重塑临床医生的选择，使得在门诊环境中进行更复杂的组织取样成为可能。医疗保健从住院转向门诊，推动了对快速安装、一次性使用且无菌、库存管理简便的针体的需求。同时，数位化整合也在不断发展，手术资料收集、设备可追溯性以及与电子健康记录的互通性，正成为系统级采购决策中的差异化因素。监管机构对安全性和可追溯性的重视持续推动着品质要求的提升，而商业策略则越来越强调捆绑式产品、服务协议和培训。因此，能够将临床证据生成、实用治疗方案和可扩展生产相结合，以应对临床医生效率和医疗保健系统成本控制这两大压力的公司，正在获得竞争优势。

对 2025 年美国关税变化对针头价值链的采购、製造决策、购买趋势和供应链韧性的影响进行全面分析。

2025年美国关税调整的累积影响已对切片穿刺针针价值链造成了显着压力，促使製造商和采购商重新评估其采购、定价和库存策略。某些进口零件和子组件的关税上调增加了依赖跨境供应链的製造商的投入成本。金属合金、精密加工零件和某些等级的聚合物受到的影响尤其严重。为此，许多供应商加快了在地采购和近岸外包的步伐，以降低贸易政策波动带来的风险。同时，一些工程团队寻求替代产品设计方案，对零件进行重新分类，以最大限度地减少关税的影响。医院和门诊医疗机构已重组采购合约并延长竞标週期，以确保在成本结构变化的情况下供应的连续性。集团采购组织也加强了谈判，以维持价格的可预测性。同时，医疗设备製造商透过提高生产效率、自动化以及与供应商更紧密的合作来控製成本，从而减轻了下游临床采购部门的压力。重点，这些调整因产品类型而异。材料清单(BOM) 简单的耗材比整合电子元件和独特子组件的复杂可重复使用系统更容易重新配置。展望未来，关税主导的奖励加速了供应商整合和区域投资决策，同时也凸显了供应链透明度、多源采购和合约弹性对于切片穿刺针针生态系统中相关人员的重要性。

详细的細項分析揭示了类型、处理方式、类别、材质、采购管道、应用和最终用户等方面的差异对产品、定价和上市策略的影响。

细分市场层面的趋势分析揭示了清晰的需求模式和策略重点，这些资讯可用于制定产品蓝图和进行商业性细分。按类型划分，市场可分为单针和双针，每种类型都满足不同的临床医生偏好和组织采集技术。因此，设计优化和临床医生培训对于在专科诊所的推广应用至关重要。依手术方式划分，穿刺切片检查、空芯针切片检查和真空辅助切片检查分别涉及不同的技术要求和临床路径。因此，器械开发商必须根据手术目的调整针头形状、管腔特性以及与辅助辅助器具的兼容性。按类别划分，一次性产品和可重复使用产品在经济性和感染控制方面存在差异，这会影响医院和门诊手术中心的采购决策。生命週期成本、灭菌通讯协定和监管要求会影响医疗机构是优先考虑一次性产品的便利性还是可重复使用产品的资本投入。按材质，金属和塑胶产品在刚性、影像伪影和製造成本方面各有优劣。这需要根据手术流程和临床医生的操作预期，精心选择合适的材质。按采购管道划分，随着医院和诊所将传统的直销关係与电子采购和数位市场结合，线上和线下销售日益并存。这也正在改变销售结构和售后支援。按应用领域划分，乳房切片、肾臟切片检查、肝臟切片检查、切片检查和摄护腺切片检查检查各自具有独特的操作和取样限制，这决定了穿刺针的长度、切割机制以及与导航系统的兼容性。按最终用户划分，门诊手术中心、诊断诊所和医院对性能特征、服务水平和采购週期有着不同的优先考虑，因此，细分市场的商业化策略必须调整通讯、管道投资和临床医生参与度，以反映最终用户的实际情况。

区域诊断和商业性特征会影响产品适应症、监管方式、製造地以及在全球市场的采用模式。

区域趋势对监管路径、临床实践模式和生产策略有显着影响，从而创造了不同的机会和风险。在美洲，完善的临床指南、影像导引手术的高普及率以及成熟的支付方环境，都为先进针头设计和整合手术系统的快速推广提供了支援。同时，监管路径着重于上市后监测和医疗设备可追溯性。在欧洲、中东和非洲，监管环境的多样性和报销政策的波动性，要求区域性的商业化策略，在集中核准、国家层面的市场进入规划和有针对性的临床证据生成之间取得平衡。在亚太地区，不断扩展的诊断基础设施、对本地生产的投资以及门诊护理模式的快速普及正在推动市场成长，尤其是对经济高效的一次性产品和可扩展培训项目的需求。供应链配置和关税风险因地区而异，影响着组件采购、製造地和库存策略的决策。此外，不同地区对可重复使用解决方案和一次性解决方案的偏好，以及门诊手术中心和独立诊断诊所的普及程度，都将影响长期的产品蓝图和服务模式。因此，各公司应根据各地区的结构和临床特征调整其研发、监管和商业化重点，以最大限度地提高相关性和普及率。

公司及竞争对手分析重点阐述现有企业、专业创新者和策略联盟如何推动产品系列的差异化、提高产品采用率以及以服务主导的客户维繫。

切片穿刺针市场的竞争格局复杂，既有成熟的医疗设备製造商，也有专注于创新领域的专业企业，还有新兴的利基供应商。成熟的医疗设备製造商拥有广泛的分销网络、完善的服务和稳固的临床医生关係，这加速了渐进式创新技术的推广应用。同时，专注于利基市场的企业则倾向于透过独特的针体几何形状、新型材料和针对特定手术的辅助器具来打造差异化技术。规模较小的公司通常更注重临床合作中的灵活性和客製化配置。常见的策略措施包括：透过有针对性的收购来拓展手术产品组合；与影像和引导系统供应商合作，提供捆绑式解决方案；以及投资临床证据以支持其性能对比声明。售后服务（培训、器械再处理协助、耗材供应协议）是重要的收入来源和客户维繫手段，尤其是在手术量和临床医生偏好起着关键作用的环境中。此外，投资于模组化设计和互通介面的公司在与寻求跨多个临床环境实现标准化的医疗系统合作时，也具有显着优势。对于新参与企业和老牌公司而言，成功都需要在以下几个方面取得平衡：检验的临床疗效、具有韧性的供应链、清晰的服务提案以及在医院和门诊处方集上的持续存在。

针对製造商和买家的具体策略建议，旨在协调产品设计、供应链韧性、临床证据开发和通路策略，以确保持续竞争力。

产业领导者应采取一系列协调一致的策略行动，以赢得临床青睐、应对成本压力并增强供应可靠性。首先，应优先开发以医疗服务提供者为中心的产品，使针头设计和操作相容性与已证实的临床疗效和易用性相匹配，从而促进产品在医院和门诊医疗机构的快速普及。其次，应透过多地点采购、尽可能选择近岸外包以及强有力的合约保护来增强供应链韧性，以降低贸易政策和关税波动的影响。同时，应优化商业模式以适应不断变化的采购行为，包括更深入地整合电子采购系统、加强数位化销售支援以及为门诊手术中心和诊断诊所提供产品客製化服务。此外，还应制定强有力的临床证据项目，以展示产品在常见应用领域的性能对比，并开发可扩展的培训和支援服务，以减少操作差异。定价策略应灵活，对高效能设备采用基于价值的定价策略，并对大批量应用提供具有成本竞争力的耗材选项。最后，我们将寻求与影像和导航设备供应商建立策略合作伙伴关係，儘早与支付方沟通报销证据需求，并考虑采用模组化产品架构，以便快速回应临床回馈和监管变化。这些措施的共同实施将提高市场应对力，保障利润率，并加强与医疗服务提供者的关係。

本研究采用稳健的混合方法研究途径，结合临床医生访谈、采购历史检验、监管和临床文献回顾以及三角验证技术，以确保研究结果的可靠性。

我们的研究途径结合了结构化的初步调查（对象包括临床医生、采购主管和行业高管）、系统性回顾同行评审的临床文献以及对监管文件和医疗设备召回资料库的分析。初步研究包括对介入放射科医生、病理学家和手术全期护理师的深入访谈，以了解手术流程的细微差别、临床医生的偏好以及尚未满足的需求。与采购和供应链相关人员的对话，让我们深入了解了竞标趋势、库存管理实践以及如何应对关税波动导致的成本变化。二次研究涵盖了医疗设备规格、监管指南、临床试验註册资讯和製造商产品资料，以检验有关技术选择和相容性的说法。我们采用资料三角测量法，将质性研究结果与监管措施和临床结果进行匹配，并使用分析框架整合供应链、监管和商业性因素的影响。品质保证程序包括与专家评审小组和临床医生进行迭代检验，以确保研究结果的实用性和准确性。限制因素和注意事项，例如区域实践模式的潜在差异以及可能随着时间推移而改变商业性条件的不断变化的贸易和监管政策，也得到了明确的阐述。

经营团队结论综合阐述了临床、商业性和供应方面的因素如何共同作用，从而确定切片穿刺针针利益相关人员的策略重点。

累积分析表明，切片穿刺针仍然是临床表现、手术效率和供应链策略的关键环节。技术进步和不断变化的医疗环境正在重新定义产品预期，而政策和贸易趋势则迫使製造商和采购商重新调整筹资策略和成本控制措施的优先顺序。细分市场分析强调了针对特定手术的设计、优化的通路和终端用户服务模式的重要性。区域监管和市场推广规划必不可少，而那些能够将临床证据、互通性解决方案和强大的生产基地相结合的公司将在竞争环境中获得优势。随着相关人员应对这些变化，最成功的机构将整合以临床医生主导的创新、严谨的供应链规划以及能够反映医院系统和门诊医疗机构实际情况的灵活商业模式。这些基础性倡议将使公司和医疗系统能够在保持营运和财务稳定的同时，改善诊断结果。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在个人化癌症治疗计划中，核心针穿刺活检设备的应用日益广泛
  • 整合人工智慧引导系统以实现精准的切片穿刺针定位
  • 感染控制和监管合规措施正在推动一次性用品的需求。
  • 开发冷冻活检切片穿刺针技术以改善介入性肺病护理中的肺组织取样。
  • 推出可操控、柔性切片穿刺针，专为微创手术中难以触及的解剖结构而优化设计。
  • 扩大液态生物检体的替代方案，以减少肿瘤诊断过程中对传统针刺活检的依赖
  • 由医疗设备製造商和影像软体供应商合作开发的即时针头导航解决方案
  • 生物相容性镍钛诺和聚合物复合材料的进步提高了切片穿刺针的耐用性，并增强了患者的安全性。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章切片穿刺针市场（按类型划分）

  • 单眼针
  • 特姆诺针

第九章 依手术方式切片穿刺针针市场

  • 穿刺切片检查
  • 核心切片检查
  • 真空辅助切片检查

第十章切片穿刺针市场（按类别划分）

  • 一次性的
  • 可重复使用的

第十一章 按材料切片穿刺针市场

  • 金属
  • 塑胶

第十二章 按采购管道切片穿刺针市场

  • 线下销售
  • 线上销售

第十三章 按应用分類的切片穿刺针市场

  • 乳房切片
  • 切片检查
  • 肝臟切片检查
  • 切片检查
  • 摄护腺切片检查

第十四章 按最终用户分類的切片穿刺针市场

  • 门诊手术中心
  • 诊断诊所
  • 医院

第十五章 各地区切片穿刺针市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章切片穿刺针市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国切片穿刺针市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Argon Medical Devices, Inc.
    • B. Braun SE
    • Becton, Dickinson and Company
    • Biomedical Srl
    • Boston Scientific Corporation
    • Cardinal Health, Inc.
    • Cook Group Incorporated
    • Doctor Japan Co., Ltd.
    • Freudenberg Medical, LLC
    • Geotek Medical
    • Hologic, Inc.
    • Inrad, Inc.
    • IZI Medical Products
    • Medax Srl
    • Medi-Tech Devices Pvt. Ltd.
    • Medtronic PLC
    • Merit Medical Systems, Inc.
    • Mermaid Medical Group
    • Olympus Corporation
    • Pajunk GmbH Medizintechnologie
    • Point Blank Medical
    • Remington Medical
    • Stryker Corporation
    • Volkmann MedizinTechnik GmbH
    • weLLgo Medical Products GmbH
Product Code: MRR-69324464D211

The Biopsy Needles Market is projected to grow by USD 1,169.50 million at a CAGR of 5.96% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 735.49 million
Estimated Year [2025] USD 777.71 million
Forecast Year [2032] USD 1,169.50 million
CAGR (%) 5.96%

Strategic introduction to why biopsy needle innovation and procurement align directly with evolving diagnostic pathways, clinical workflows and care setting transformation

Biopsy needles represent a foundational component of modern diagnostic pathways, enabling clinicians to obtain tissue with minimal invasiveness while informing definitive clinical decisions. Over the past decade, incremental advances in imaging guidance, needle design and materials science have expanded the clinical scope of percutaneous biopsy procedures across organ systems. As clinical pathways shift toward earlier, image-driven detection and precision medicine, the needle itself has become more than a passive instrument: it is a convergence point for procedural efficiency, safety, and downstream diagnostic yield. Consequently, manufacturers, clinicians and procurement leaders must evaluate product performance, procedural fit and lifecycle economics in tandem. Moreover, evolving care settings-from inpatient hospital suites to ambulatory surgical centers and diagnostic clinics-alter device demand profiles and service expectations, prompting manufacturers to refine portfolios and commercial approaches. In this context, stakeholders should prioritize a clear understanding of procedural requirements, clinician workflows and the interplay between device attributes and diagnostic outcomes. By doing so, product development and commercialization strategies can better align with the operational realities of contemporary biopsy practice and with the evolving expectations of clinicians, patients and health systems.

High-impact shifts redefining biopsy needle development and procurement driven by imaging integration, site-of-care migration, and regulatory and digital imperatives

The biopsy needle landscape is undergoing transformative shifts driven by technological innovation, changing site-of-care dynamics and heightened expectations for diagnostic accuracy and patient experience. Advancements in needle geometries, coatings and imaging-compatible designs are reducing sampling error and procedure time while expanding the range of minimally invasive interventions clinicians can perform. At the same time, broader adoption of vacuum-assisted systems and improvements in image-guidance platforms are reshaping clinician preferences and enabling more complex tissue sampling in outpatient settings. Shifting care from inpatient to ambulatory environments has prompted demand for needles optimized for rapid setup, single-use sterility and simplified inventory management. In parallel, digital integration is increasing: procedural data capture, device traceability and interoperability with electronic medical records are becoming differentiators for system-level purchasing decisions. Regulatory emphasis on safety and traceability continues to elevate quality requirements, while commercial strategies now place greater weight on bundled offerings, service contracts and training. As a result, the competitive playing field rewards firms that combine clinical evidence generation, practical procedural solutions and scalable manufacturing, enabling them to meet the simultaneous pressures of clinician efficacy and health system cost containment.

Comprehensive analysis of how United States 2025 tariff changes reshaped sourcing, manufacturing decisions, procurement dynamics, and supply chain resilience across the needle value chain

The cumulative implications of tariff adjustments instituted by the United States in 2025 have introduced measurable pressure across the biopsy needle value chain, prompting manufacturers and buyers to reassess sourcing, pricing and inventory strategies. Increased duties on certain imported components and subassemblies have elevated input costs for manufacturers that rely on cross-border supply networks, particularly for metal alloys, precision-machined parts and specific polymer grades. In response, many suppliers accelerated localization and nearshoring initiatives to reduce exposure to trade policy volatility, while some engineering teams explored product design alternatives to shift component classification and minimize tariff impact. Hospitals and ambulatory providers reacted by revisiting procurement contracts and extending tender cycles to secure supply continuity under changed cost structures, and group purchasing organizations intensified negotiations to retain predictable pricing. Simultaneously, device companies pursued cost containment through production efficiency, automation and closer vendor partnerships, which moderated downstream pressure on clinical purchasers. Importantly, these adaptations varied by product category: disposable items with simple bill-of-materials were easier to reconfigure than complex reusable systems with integrated electronics or proprietary subcomponents. Looking forward, tariff-driven incentives accelerated supplier consolidation and regional investment decisions, while also reinforcing the importance of supply chain transparency, multi-origin sourcing and contractual flexibility for stakeholders across the biopsy needle ecosystem.

In-depth segmentation insight clarifying how type, procedure, category, material, purchasing channel, application and end-user distinctions shape product, pricing and go-to-market choices

Segment-level dynamics reveal distinct demand patterns and strategic priorities that should inform product roadmaps and commercial segmentation. Based on Type, the market differentiates between monopty needle and temno needle, each serving unique clinician preferences and tissue-sampling techniques; design optimization and clinician training are therefore critical for adoption within specialty practices. Based on Procedure, aspiration biopsy, core biopsy and vacuum-assisted biopsy follow different technical requirements and clinical pathways, so device developers must match needle geometry, inner lumen characteristics and compatibility with procedural accessories to procedural intent. Based on Category, disposable and reusable options carry divergent economic and infection-control implications, which impacts purchasing decisions by hospitals and ambulatory surgical centers; lifecycle costs, sterilization protocols and regulatory requirements influence whether institutions favor single-use convenience or reusable capital investments. Based on Material, metal and plastic constructions offer trade-offs in rigidity, imaging artifact and manufacturing cost, requiring careful material selection aligned to procedural contexts and clinician handling expectations. Based on Purchasing Channel, offline sales and online sales increasingly coexist as hospitals and clinics blend traditional direct sales relationships with eProcurement and digital marketplaces, changing salesforce models and aftersales support. Based on Application, breast biopsy, kidney biopsy, liver biopsy, lung biopsy and prostate biopsy each impose specific access and sampling constraints, shaping needle length, cutting mechanisms and compatibility with guidance systems. Based on End User, ambulatory surgical centers, diagnostic clinics and hospitals prioritize different performance attributes, service levels and procurement cycles, so segmentation-aware commercialization strategies must adapt messaging, channel investment and clinician engagement to reflect end-user operational realities.

Regional diagnostic and commercial nuances that influence product adaptation, regulatory approach, manufacturing footprints and adoption patterns across global markets

Regional dynamics exert meaningful influence on regulatory pathways, clinician practice patterns and manufacturing strategies, producing differentiated opportunities and risks. In the Americas, established clinical guidelines, high adoption of image-guided procedures and a well-developed payer environment support rapid uptake of advanced needle designs and integrated procedural systems, while regulatory pathways emphasize post-market surveillance and device traceability. In Europe, Middle East & Africa, regulatory diversity and variable reimbursement landscapes mean commercialization approaches must be regionally tailored, balancing centralized approvals with country-level market access planning and targeted clinical evidence generation. In Asia-Pacific, growth is being driven by expanding diagnostic infrastructure, investments in local manufacturing and rapid adoption in outpatient care models, with particular demand for cost-efficient disposables and scalable training programs. Across all regions, supply chain configurations and tariff exposures differ, influencing decisions about component sourcing, manufacturing location and inventory strategy. Additionally, regional preferences for reusable versus disposable solutions and the penetration of ambulatory surgical centers versus standalone diagnostic clinics shape long-term product roadmaps and service models. Consequently, companies should align R&D, regulatory and commercial priorities with the specific structural and clinical characteristics of each region to maximize relevance and uptake.

Corporate and competitive analysis revealing how legacy manufacturers, focused innovators and strategic partnerships drive differentiation, adoption and service-led retention across product portfolios

Competitive dynamics in the biopsy needle arena reflect a mix of legacy device manufacturers, specialized innovators and emerging niche suppliers. Established medical device manufacturers maintain broad distribution networks, integrated services and established clinician relationships that can accelerate adoption of incremental innovations. Conversely, focused niche players often drive technical differentiation through proprietary needle geometries, novel materials and procedure-specific adjuncts, while smaller firms typically emphasize agility in clinical collaboration and custom configurations. Strategic behaviors observed across companies include targeted acquisitions to augment procedural portfolios, partnerships with imaging and guidance system providers to deliver bundled solutions, and investments in clinical evidence to support comparative performance claims. Aftermarket services-training, instrument reprocessing support and consumable supply agreements-have become important revenue and retention levers, particularly in settings where procedure volume and clinician preference exert heavy influence. Moreover, companies that invest in modular designs and interoperable interfaces have an advantage when engaging health systems seeking to standardize across multiple sites of care. For market entrants and incumbents alike, successful players will balance clinical validation, supply chain robustness and a clear service proposition to secure durable placement in hospital and outpatient formularies.

Actionable strategic recommendations for manufacturers and purchasers to align product design, supply chain resilience, clinical evidence development and channel strategies for sustained competitiveness

Industry leaders should pursue a coordinated set of strategic actions to capture clinical preference, manage cost pressure and strengthen supply reliability. First, prioritize clinician-centered product development that aligns needle design and procedure compatibility with documented clinical outcomes and ease-of-use, enabling faster uptake in both hospital and outpatient settings. Next, invest in supply chain resilience through multi-origin sourcing, nearshoring where feasible and stronger contractual protections to mitigate trade-policy and tariff volatility. Simultaneously, refine commercial models to reflect evolving purchasing behaviors by expanding eProcurement integration, enhancing digital sales enablement and tailoring offerings for ambulatory surgical centers and diagnostic clinics. Additionally, build robust clinical-evidence programs that demonstrate comparative performance across commonly performed applications, while also creating scalable training and support services to reduce procedural variability. Pricing strategies should be flexible, incorporating value-based pricing for high-performance devices and cost-competitive disposable options for volume-driven applications. Finally, pursue strategic partnerships with imaging and guidance vendors, engage with payers early on reimbursement evidence needs, and consider modular product architectures to respond rapidly to clinical feedback and regulatory changes. Together, these measures will improve market responsiveness, protect margins and strengthen institutional relationships.

Robust mixed-methods research approach combining clinician interviews, procurement validation, regulatory and clinical literature review plus triangulation for high-integrity insights

The research approach combined structured primary engagement with clinicians, procurement leads and industry executives, systematic review of peer-reviewed clinical literature and analysis of regulatory filings and device recall databases. Primary inputs included in-depth interviews with interventional radiologists, pathologists and perioperative nurses to capture procedural nuances, clinician preferences and unmet needs. Procurement and supply chain conversations provided insight into tender dynamics, inventory practices and responses to tariff-driven cost changes. Secondary research encompassed technical device specifications, guidance from regulatory agencies, clinical trial registries and manufacturer product literature to validate engineering choices and compatibility claims. Data triangulation methods were applied to cross-check qualitative insights against regulatory actions and clinical outcomes, and analytic frameworks were used to synthesize supply chain, regulatory and commercial implications. Quality assurance steps included expert review panels and iterative validation with practicing clinicians to ensure practical relevance and accuracy. Limitations and caveats were explicitly documented, including potential variability across local practice patterns and the evolving nature of trade and regulatory policy that may alter commercial conditions over time.

Executive conclusion synthesizing how clinical, commercial and supply-side forces converge to define strategic priorities for biopsy needle stakeholders

The cumulative analysis underscores that biopsy needles remain a critical intersection of clinical performance, procedural efficiency and supply chain strategy. Technological progress and shifting care settings are redefining product expectations, while policy and trade developments are compelling manufacturers and purchasers to reprioritize sourcing and cost-management tactics. Segmentation insights highlight the need for procedure-specific design, channel-tailored commercialization and end-user-aware service models. Regional nuances demand customized regulatory and market access planning, and competitive dynamics reward firms that combine clinical evidence, interoperable solutions and resilient manufacturing footprints. As stakeholders navigate these changes, the most successful organizations will integrate clinician-led innovation, disciplined supply chain planning and flexible commercial models that reflect the realities of both hospital systems and outpatient providers. These foundational actions will position companies and health systems to improve diagnostic outcomes while maintaining operational and financial stability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of core needle biopsy devices for personalized oncology treatment planning
  • 5.2. Integration of artificial intelligence guidance systems in biopsy needle placement for enhanced accuracy
  • 5.3. Rising demand for single-use disposable biopsy needles driven by infection control and regulatory compliance incentives
  • 5.4. Development of cryobiopsy needle techniques for improved lung tissue sampling in interventional pulmonology practice
  • 5.5. Emergence of steerable and flexible biopsy needles optimized for challenging anatomical site access in minimally invasive procedures
  • 5.6. Expansion of liquid biopsy alternatives reducing reliance on traditional needle sampling in oncology diagnostics pipelines
  • 5.7. Collaborative partnerships between medical device manufacturers and imaging software providers for real-time needle navigation solutions
  • 5.8. Advancements in biocompatible nitinol and polymer blend materials enhancing biopsy needle durability and patient safety profiles

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopsy Needles Market, by Type

  • 8.1. Monopty Needle
  • 8.2. Temno Needle

9. Biopsy Needles Market, by Procedure

  • 9.1. Aspiration Biopsy
  • 9.2. Core Biopsy
  • 9.3. Vacuum-Assisted Biopsy

10. Biopsy Needles Market, by Category

  • 10.1. Disposable
  • 10.2. Reusable

11. Biopsy Needles Market, by Material

  • 11.1. Metal
  • 11.2. Plastic

12. Biopsy Needles Market, by Purchasing Channel

  • 12.1. Offline Sales
  • 12.2. Online Sales

13. Biopsy Needles Market, by Application

  • 13.1. Breast Biopsy
  • 13.2. Kidney Biopsy
  • 13.3. Liver Biopsy
  • 13.4. Lung Biopsy
  • 13.5. Prostate Biopsy

14. Biopsy Needles Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Diagnostic Clinics
  • 14.3. Hospitals

15. Biopsy Needles Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Biopsy Needles Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Biopsy Needles Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Argon Medical Devices, Inc.
    • 18.3.2. B. Braun SE
    • 18.3.3. Becton, Dickinson and Company
    • 18.3.4. Biomedical Srl
    • 18.3.5. Boston Scientific Corporation
    • 18.3.6. Cardinal Health, Inc.
    • 18.3.7. Cook Group Incorporated
    • 18.3.8. Doctor Japan Co., Ltd.
    • 18.3.9. Freudenberg Medical, LLC
    • 18.3.10. Geotek Medical
    • 18.3.11. Hologic, Inc.
    • 18.3.12. Inrad, Inc.
    • 18.3.13. IZI Medical Products
    • 18.3.14. Medax Srl
    • 18.3.15. Medi-Tech Devices Pvt. Ltd.
    • 18.3.16. Medtronic PLC
    • 18.3.17. Merit Medical Systems, Inc.
    • 18.3.18. Mermaid Medical Group
    • 18.3.19. Olympus Corporation
    • 18.3.20. Pajunk GmbH Medizintechnologie
    • 18.3.21. Point Blank Medical
    • 18.3.22. Remington Medical
    • 18.3.23. Stryker Corporation
    • 18.3.24. Volkmann MedizinTechnik GmbH
    • 18.3.25. weLLgo Medical Products GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. BIOPSY NEEDLES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. BIOPSY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOPSY NEEDLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GCC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GCC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GCC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. GCC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 286. GCC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 287. GCC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 288. GCC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 289. GCC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. GCC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. GCC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. GCC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. GCC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. GCC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. GCC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. GCC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. G7 BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. G7 BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. G7 BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. G7 BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 334. G7 BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 335. G7 BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 336. G7 BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 337. G7 BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 338. G7 BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 339. G7 BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 340. G7 BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 341. G7 BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. G7 BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. G7 BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 344. G7 BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 345. NATO BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 346. NATO BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 347. NATO BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. NATO BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 349. NATO BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 350. NATO BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 351. NATO BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 352. NATO BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 353. NATO BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 354. NATO BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 355. NATO BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 356. NATO BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 357. NATO BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 358. NATO BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 359. NATO BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 360. NATO BIOPSY NEEDLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 361. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 362. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 363. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY TYPE, 201